Please login to the form below

Not currently logged in

Shire’s angioedema drug Takhzyro recommended in Europe

ShireAnalysts expect the drug to make around $1.8bn in peak sales

Encouraging data for GenSight’s blinding retinal disease gene therapy

GenSightBetter results after April's setback

Novartis buys cancer specialist Endocyte for $2.1bn

Novartis Basel WebAcquisition includes 'universal' CAR-T platform

UK ‘unicorn’ Oxford Nanopore bags $65m backing from Amgen

Oxford NanaporeBig biopharma investment good news for gene sequencing company

The Gallery

A visual showcase of agency work. Track down an agency from the image, track down your competitors' work, search by product or therapy area to pull up, for example, cardiovascular campaigns. Click here for a portfolio of hundreds of campaign visuals – updated regularly – free for you to reference. Agencies – to add your work to The Gallery please contact us.

The case for a second Brexit referendum: “We need the informed consent of the people”

Dr Phillip Lee MP is fighting to keep the UK in the EMA network - and for a second referendum

Phillip Lee

Your excellent marketing team: let the world know about it

Enter the PMEA and let the world know about it

Pharma social media

Posting frequency is down as companies take a ‘less is more’ approach

fig 1

New starters join Four Communications, Emotive and McCann Health

The latest movers in healthcare communications


Let's throw it against the wall and see what sticks...

Why including drug costs in DTC advertising is an idea full of holes

Novartis launch NET cancer community app

Galaxies of Hope aims to provide support to cancer patients

Galaxies of Hope

Big Pharma, Little Pharma

Evolution provides options for those firms that can’t be huge

darwins medicine

AI UK – one year on

Are patients still cautiously embracing new healthcare tools?

Duncan Arbour

Featured jobs

Subscribe to our email news alerts


Add my company

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...